For citations:
Bukatina T.M., Kazakov A.S., Velts N.Yu., Darmostukova M.A., Zatolochina K.E., Alyautdin R.N., Dobrynin V.P., Romanov B.K. Ketoacidosis as unexpected adverse reaction SGLT2 inhibitor. Safety and Risk of Pharmacotherapy. 2016;(4):23-26. (In Russ.)
Email this article 